Millions of HIV patients in Africa face an impending drug shortage, as the World Health Organization (WHO) warns that the U.S. government’s suspension of foreign aid is disrupting critical health programs.
WHO Director-General Dr. Tedros Adhanom Ghebreyesus cautioned that the funding halt, announced by U.S. President Donald Trump, could undo 20 years of progress, potentially leading to over 10 million new HIV cases and three million HIV-related deaths in the coming years.
Countries at Risk of Running Out of HIV Drugs
The WHO identified eight countries—including Nigeria, Kenya, Lesotho, South Sudan, Burkina Faso, and Mali in Africa, alongside Haiti and Ukraine—as at risk of exhausting their supply of life-saving antiretroviral (ARV) medicines within months.
These nations rely heavily on the U.S. President’s Emergency Plan for AIDS Relief (PEPFAR), a program launched in 2003, which has provided free or subsidized HIV treatment, testing, and prevention services worldwide.
Impact of the U.S. Aid Freeze
The U.S. foreign aid freeze, announced on Trump’s first day in office in January 2025, put PEPFAR operations on hold by disrupting logistics, medical supply chains, and funding. Although a waiver was issued in February, it has not been enough to restore services, and shipments of critical HIV medications remain stalled.
As a result:
- More than 50 countries have seen an immediate halt in HIV-related services.
- Key U.S. funding agencies, including USAID, have terminated programs supporting global health initiatives.
- Millions of HIV patients who depend on free or subsidized ARV drugs now face uncertainty and potential treatment interruptions.
A Crisis for Sub-Saharan Africa
Sub-Saharan Africa is home to 25 million people living with HIV, representing two-thirds of the global total of 38 million HIV patients.
In Nigeria, nearly two million people rely on foreign aid-funded HIV medications. Similarly, Kenya, which has the seventh-largest HIV-positive population in the world (1.4 million), faces a looming crisis.
Dr. Tedros urged the U.S. government to reconsider its stance, emphasizing that global health aid does not just save lives in Africa but also protects the U.S. from potential health crises spreading internationally.
A Call for Urgent Action
The WHO is now working with international donors and governments to find alternative funding sources. However, Dr. Tedros stressed that any transition must be orderly and humane, warning that a sudden withdrawal of U.S. support would have devastating consequences.
With millions of lives at stake, global health advocates are calling for a rapid resolution to the funding freeze, before the crisis spirals into one of the worst setbacks in the fight against HIV/AIDS in decades.
